What was PharmaRoth Labs’s price range in the past 12 months?
PharmaRoth Labs lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is PharmaRoth Labs’s market cap?
PharmaRoth Labs’s market cap is $351.
When is PharmaRoth Labs’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is PharmaRoth Labs overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does PharmaRoth Labs pay dividends?
PharmaRoth Labs does not currently pay dividends.
What is PharmaRoth Labs’s EPS estimate?
PharmaRoth Labs’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PharmaRoth Labs have?
PharmaRoth Labs has 351,182,000 shares outstanding.
Which hedge fund is a major shareholder of PharmaRoth Labs?
Currently, no hedge funds are holding shares in ROTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PharmaRoth Labs
PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes. The company was formerly known as Fero Industries Inc. and changed its name to PharmaRoth Labs, Inc. in March 2013. PharmaRoth Labs, Inc. was founded in 2000 and is based in Las Vegas, Nevada.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Luis Manuel Ornelas Lopez
Employees
0
Website
www.feroindustries.com
Address
8250 West Charleston Boulevard, Las Vegas, NV, 89117, US